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Book Review
This is an updated and thoroughly revised version of the WHO 'blue book' on endocrine tumors, originally published in 1980. Prepared by a group of world-renowned pathologists (this time only from Europe and North America), it is a consensus document reflecting our current understanding of endocrine tumor pathology. It was conceived to provide guidance to practicing pathologists, and I am sure that it will be used a great deal. It will help in establishing some uniformity in the nomenclature and, thus, will enable better communication among pathologists from different countries. On the other hand, it is far from being a definitive document, and more like a work in progress. Thus, it also could provide a good basis for broader discussions and stimulate those interested in endocrine neoplasms to explore some of the undefined or controversial entities. It also could be the startline for the next group of pathologists who will carry on the work into the 21st century. The editors and the contributors to this mongraph deserve to be congratulated on their effort. As a result of their work, there is a solid WHO classification of tumors, which includes also the most important tumor-like conditions. Obviously these conditions need to be considered when dealing with endocrine tumors, which merge imperceptibly with hyperplasias, dysplasias, and even developmental disorders. The exegetical narrative that follows the classification provides useful definitions and commentaries and is supplemented with well-chosen color photographs. The text contains many useful facts and diagnostic pearls-something for novices and something for more experienced pathologists. Personally, I would have appreciated references supporting some of the statements (especially those that I did not agree with!), and I would urge the powers that be in the WHO to allow the use of references in the next edition. This reasonably priced booklet belongs in the libraries of all diagnostic pathologists, but it should be used by clinical oncologists as well. As intended, it deserves to be read and used worldwide.
